Johnson & Johnson Anticipates Covid Vaccine Sales of $2.5 Billion in 2021

Johnson & Johnson (NYSE:JNJ) is expecting its COVID-19 vaccine to reach $2.5 billion in sales this year, despite concerns about the injection’s ef…

Leave a Reply

Your email address will not be published. Required fields are marked *